financetom
Business
financetom
/
Business
/
Embraer Outlook Remains Firm As Backlog Grows Across Segments
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Embraer Outlook Remains Firm As Backlog Grows Across Segments
Nov 4, 2025 11:27 AM

Embraer S.A. ( EMBJ ) shares fell on Tuesday after the company announced record third-quarter 2025 results, highlighted by higher deliveries, a strong backlog, and reaffirmed full-year guidance despite mixed financial performance.

Revenue rose 18% year over year to $2.004 billion, marking an all-time high for the third quarter, while adjusted earnings of 30 cents per share topped the 10-cent estimate.

Sales of $2.004 billion fell short of the $2.190 billion estimate, and adjusted EBIT was $172 million, resulting in an 8.6% margin.

Also Read: Boeing’s 737 Momentum Fuels Delivery Surge, Embraer Stays On Track

The company delivered 62 aircraft during the quarter—20 commercial jets, 41 executive jets, and one defense aircraft—up 5% from a year ago.

The firm order backlog reached a record $31.3 billion, up 5% sequentially and 38% year-over-year, with growth across all business units.

Commercial Aviation revenue increased 31% to $618 million on stronger pricing, mix, and volumes. Executive Aviation revenue grew 4% to $583 million, while Defense & Security rose 27% to $278 million, driven by higher KC-390 deliveries and a one-off contract adjustment.

Services & Support revenue advanced 16% to $493 million on broad-based volume growth.

Adjusted free cash flow excluding Eve was $300 million, supported by improved working capital and higher deliveries.

Embraer ( EMBJ ) ended the quarter with $2.082 billion in consolidated cash, $2.109 billion in gross debt, and a stand-alone net cash position of $(439) million.

Outlook:

Embraer ( EMBJ ) reaffirmed its 2025 outlook, guiding for $7.0–$7.5 billion in revenue versus a $7.615 billion estimate, an adjusted EBIT margin of 7.5%–8.3%, and adjusted free cash flow of $200 billion or higher.

It expects 77–85 Commercial Aviation deliveries and 145–155 Executive Aviation deliveries for the year.

Price Action: EMBJ shares were trading lower by 4.16% to $61.98 at last check Tuesday.

Read Next:

Uber’s Strong Performance Gets Overshadowed By CEOs Robotaxi Comment

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Groupe Dynamite Q3 Adjusted Profit, Revenue Advance
Groupe Dynamite Q3 Adjusted Profit, Revenue Advance
Dec 17, 2024
07:35 AM EST, 12/17/2024 (MT Newswires) -- Groupe Dynamite ( GRGDF ) on Tuesday reported higher third-quarter adjusted profit and revenue that beat estimates. The company, which operates two women's clothing brands, said adjusted diluted net earnings increased to $43.7 million, or $0.41 per share, from $35.7 million, or $0.33 per share, last year. The result beat the consensus analyst...
KBR Wins $88 Million US Air Force Contract
KBR Wins $88 Million US Air Force Contract
Dec 17, 2024
07:36 AM EST, 12/17/2024 (MT Newswires) -- KBR (KBR) said Tuesday it has won a roughly $88 million task order contract from the US Air Force's 774 Enterprise Sourcing Squadron under the Department of Defense Information Analysis Center's multiple-award contract vehicle. The contract is meant to promote rapid prototyping of new technologies into unmanned aviation platforms and systems, the company...
Merck's Respiratory Syncytial Virus Drug's Biologics License Application Accepted by FDA
Merck's Respiratory Syncytial Virus Drug's Biologics License Application Accepted by FDA
Dec 17, 2024
07:36 AM EST, 12/17/2024 (MT Newswires) -- Merck ( MRK ) said Tuesday that the US Food and Drug Administration has accepted its Biologics License Application for clesrovimab, the company's investigational drug to protect infants from respiratory syncytial virus disease during their first season of exposure. The FDA has set a target action date of June 10 for the drug,...
Marimaca Copper Secures Option to Buy Madrugador Project in Chile
Marimaca Copper Secures Option to Buy Madrugador Project in Chile
Dec 17, 2024
07:32 AM EST, 12/17/2024 (MT Newswires) -- Marimaca Copper ( MARIF ) said Tuesday that it signed a binding option agreement to acquire the Madrugador project in Chile. The company said Madrugador is located near the Pampa Medina project, and the acquisition consolidated its ownership of the southern extent of the Sierra de Medina property package. Under the terms, Marimaca...
Copyright 2023-2026 - www.financetom.com All Rights Reserved